Prospective Multicenter Study for Evaluation of Safety, Efficacy, and Esthetic Results of Cross-Linked Polyacrylamide Hydrogel in 81 Patients
Authors:
- 1 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 35 (Sup 1) , 338-343
Abstract
Cross-linked polyacrylamide hydrogel, a nonabsorbable soft-tissue filler, has given promising results regarding efficacy and safety at 24 months of follow-up, but because adverse reactions have been described years after injection of some other fillers, a prolonged follow-up was required. To examine the safety and efficacy of the hydrogel in facial contouring after 36 to 48 months (mean 40 months). In this prospective multicenter trial, the esthetic results and safety of the treatments were assessed at 36 to 48 months, and the results were compared with those seen previously. Eighty-one patients participated. The investigator rated esthetic results as very good or good in 99% of cases, and 98% of patients rated esthetic results as very satisfactory or satisfactory. Two of nine reported adverse events were possibly related to hydrogel treatment. One was initial infection after a touch-up, and one was continuous itching 1 year after injection. The polyacrylamide hydrogel filler was still well tolerated after 36 to 48 months with no long-term unexpected adverse events and no loss of filler effect.Keywords
This publication has 16 references indexed in Scilit:
- Tissue Integration of Polyacrylamide Hydrogel: An Experimental Study of Periurethral, Perivesical, and Mammary Gland Tissue in the PigDermatologic Surgery, 2008
- Polyacrylamide Hydrogel Injection in the Management of Human Immunodeficiency Virus–Related Facial Lipoatrophy: A 2-Year Clinical ExperiencePlastic and Reconstructive Surgery, 2008
- Normal and Pathologic Tissue Reactions to Soft Tissue Gel FillersDermatologic Surgery, 2007
- Reconstructive Treatment for Antiretroviral-Associated Facial Lipoatrophy: A Prospective Study Comparing Autologous Fat and Synthetic SubstancesAIDS Patient Care and STDs, 2006
- Avoiding and Treating Dermal Filler Complications Table 1. Classification of U.S. Food and Drug Administration–Approved InjectablesPlastic and Reconstructive Surgery, 2006
- Injectable Skin FillersClinics in Plastic Surgery, 2005
- The Evolution of Soft Tissue Fillers in Clinical PracticeDermatologic Clinics, 2005
- Review of Injectable Materials for Soft Tissue AugmentationFacial Plastic Surgery, 2004
- The History of Substances for Soft Tissue AugmentationDermatologic Surgery, 2000
- THE USE OF SILICONES IN PLASTIC SURGERYPlastic and Reconstructive Surgery, 1973